Chicago, IL; November 30, 2019 – ComplianceXL has signed a contract with a leading batteries ‘manufacturer in the US, IMDS consulting and MDS reporting for their OEM customers.
The client is a global major in the production of batteries for multiple applications such as motive power, reserve power, aerospace, and defense. The client is known for manufacturing and distributing reserve power and motive power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosure solutions to automobile customers worldwide.
This exclusive IMDS support engagement constitutes of various elements such as ongoing consulting on IMDS requirement, supplier engagement and training to update the MDS data into IMDS platform, supplier IMDS validation and IMDS reporting of OEMs products. ComplianceXL will setup a dedicated team of IMDS engineers led by a senior compliance consultant to make sure client is successfully compliant with the regulation.
The scope of work includes:
“Increasing complexity and frequent changes in regulations are big challenges for the suppliers of automotive industry, it’s imperative for them to maintain the integrity and accuracy of the substance data. Our IMDS team helps the suppliers to ensure accurate reporting of IMDS which enable the suppliers to meet the IMDS requirement and faster PPAP approval process for shipment.” says CK
Bharathan, Head – Compliance Solutions, Compliance XL.
About ComplianceXL:
ComplianceXL is the Compliance Solutions Division of Enventure, a leader in the compliance business since 2003. ComplianceXL is a one-stop solution for all supply chain compliance requirements, ranging from consulting and training to software deployment and compliance documentation. By implementing a transparent and well-structured compliance program, ComplianceXL enables clients and all key stakeholders to follow an integrated process, to meet obligations. Beyond an initial implementation, also provides ongoing support to comply with all regulations by keeping you updated with the latest directives.